|
Key Performance Indicators |
2021 |
2020 |
2019 | 2018 | 2017 | |
|
New patent applications filed (per year) |
11 |
7 |
3 | 2 | 2 | |
|
US patents granted (per year) |
2 |
3 |
2 | 1 | 2 | |
|
EU patents granted (per year) |
4 |
3 | 1 | 1 | ||
| Total number of patents | 21 | 15 | 15 | |||
| Total number of EU and US patents | 33 | 30 | 21 | 21 | 15 | |
| Total number of patent applications | 10 | |||||
|
Licenses |
16 |
13 |
11 | 11 | 11 |
2021
GRANTED US PATENTS
- RNA-directed DNA cleavage by the Cas9-crRNA complex (US9637739B2; US10844378B2)
- Systems and methods for barcoding nucleic acids (US10596541B2; US11052368B2)*
- System and method for a biomimetic fluid processing (US10343163B2; US10710073B2; US9795965B1)*
- Programmable RNA shredding by the type III-A CRISPR-Cas system of Streptococcus Thermophilus (US10385336B2)
- Derivatization of biomolecules by covalent coupling of non-cofactor compounds using methyltransferases (US8822146B2)
- Conversion of alpha-hydroxyalkylated residues in biomolecules using methyltransferases (US8889352B2; US9505797B2)
- Fluorinated benzenesulfonamides as inhibitors of carbonic anhydrase (US9725467B2)
- Nucleic acid production and sequence analysis (US9347093B2; US9988673B2)
- New s-adenosyl-L-methionine analogues with extended activated groups for transfer by methyltransferases (US8008007B2)*
- Process for the production of monoclonal antibodies using chimeric VLPS (US7919314B2)
- 5-Aryl-4(5-substituted 2,4-dihydraxyphenyl)-1,2,3-thiadiazoles as inhibitors of HSP90 chaperone and the intermediates for production thereof (US8314132B2)
- Analysis of single-stranded RNA (US11008605B2).
GRANTED EU PATENTS
- RNA-directed DNA cleavage by the Cas9-crRNA complex (EP2828386B1)
- Systems and methods for barcoding nucleic acids (EP3134536B1; EP3299469B1)*
- System and method for a biomimetic fluid processing (EP2941642B1)*
- Programmable RNA shredding by the type III-A CRISPR-Cas system of Streptococcus Thermophilus (EP3189140B1)
- Conversion of alpha-hydroxyalkylated residues in biomolecules using methyltransferases (EP2414527B1)
- Derivatization of biomolecules by covalent coupling of non-cofactor compounds using methyltransferases (EP2414528B1)
- Fluorinated benzenesulfonamides as inhibitors of carbonic anhydrase (EP2914583B1)
- Nucleic acid production and sequence analysis (EP2776575B1)
- Production of selenoproteins (selprot) (EP3019194B1)
- Analysis of single-stranded RNA (EP3271478B1)
- System and method for synthesis of DNA particles and use thereof (EP3402594B1)*
- 5-Aryl-4(5-substituted 2,4-dihydraxyphenyl)-1,2,3-thiadiazoles as inhibitors of HSP90 chaperone and the intermediates for production thereof (EP2268626B1)
- New s-adenosyl-L-methionine analogues with extended activated groups for transfer by methyltransferases (EP1874790B1)*
- Benzimidazo [1,2-C][1,2,3] thiadiazol-7-sulfonamides as inhibitors of carbonic anhydrase and the intermediates for production thereof (EP2054420B1)
GRANTED JP PATENTS
- RNA-directed DNA cleavage by the Cas9-crRNA complex (JP6423338B2)
- System and method for a biomimetic fluid processing (JP6429794B2)*
- New s-adenosyl-L methionine analogues with extended activated groups for transfer by methyltransferases (JP08008007B2)*
- Systems and methods for barcoding nucleic acids (JP6853667B2)*
PATENT APPLICATIONS
- RNA-directed DNA cleavage by the Cas9-crRNA complex (US20150291961A1; US20180187195A1; JP2019030321A; JP2021019617A)
- Systems and methods for barcoding nucleic acids (US20150298091A1; EP3456846A1; US20210379555A1)*
- System and method for a biomimetic fluid processing (US20200316597A1)*
- System and method for producing target biological substances (EP3712612A1)*
- Selective inhibitors of carbonic anhydrase (US20180222856A1; EP3328833A1)
- System and method for synthesis of DNA particles and use thereof (US20190002943A1)*
- Production of cyclic adenylates and their use as allosteric regulators (EP3630966A1); US20210130799A1
- Methods for the identification and characterization of double-strand break sites and compositions and uses thereof (US20210147909A1; EP3790993A1)*
- Characterization of prostate cancer using DNA methylation assay (PCT/IB2019/056204)
- N 4-modified cytidine nucleotides and their use (EP3681897A1; US20200270295A1)
- Systems and methods for encapsulation and multi-step processing of biological samples (WO2020255108A1; US20200400538A1)*
- Method for generating functional protein sequences with generative adversarial networks (WO2021059066A1)*
- Methods and compositions for noninvasive prenatal diagnosis through targeted covalent labeling of unmodified genomic sites (WO2021198726A1)
- Clear cell renal cell carcinoma biomarkers and uses thereof (US63128874)*
- Carbonic anhydrase inhibitors synthesized on interconnecting linker chains (PCT/IB2021/061310)
- Antibodies For Photoactive Protein Manipulation (EP21187460.7)
- Catalytic biomolecule activity recording into DNA sequence (EP3864168A1*; US20210355486A1*)
* Jointly owned patent with a foreign research organization and/or company